[Pharmacokinetic, bacteriological and clinical evaluation of tazobactam/piperacillin in pediatrics].

@article{Iwai1998PharmacokineticBA,
  title={[Pharmacokinetic, bacteriological and clinical evaluation of tazobactam/piperacillin in pediatrics].},
  author={Naoichi Iwai and Hiroyoshi Nakamura and Mitsunobu Miyazu},
  journal={The Japanese journal of antibiotics},
  year={1998},
  volume={51 5},
  pages={346-61}
}
Pharmacokinetic, bacteriological and clinical studies were performed in pediatrics on tazobactam/piperacillin (TAZ/PIPC), a combined drug of a new beta-lactamase inhibitor tazobactam and piperacillin at a ratio of 1:4. 1. Serum levels and urinary excretions of TAZ, PIPC and desethyl piperacillin (DEt-PIPC), a metabolite of PIPC, after one shot intravenous… CONTINUE READING